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Many studies support the pro-nociceptive role of brain-derived neurotrophin factor (BDNF) in pain processes in the peripheral and
central nervous system. We have previously shown that nociceptor-derived BDNF is involved in inﬂammatory pain. Microglial-
derived BDNF has also been shown to be involved in neuropathic pain. However, the distinct contribution of primary afferent-
derived BNDF to chronic pain processing remains undetermined. In this study, we used Avil-CreERT2 mice to delete Bdnf from all
adult peripheral sensory neurons. Conditional BDNF knockouts were healthy with no sensory neuron loss. Behavioural assays and
in vivo electrophysiology indicated that spinal excitability was normal. Following formalin inﬂammation or neuropathy with a
modiﬁed Chung model, we observed normal development of acute pain behaviour, but a deﬁcit in second phase formalin-induced
nocifensive responses and a reversal of neuropathy-induced mechanical hypersensitivity during the later chronic pain phase in
conditional BDNF knockout mice. In contrast, we observed normal development of acute and chronic neuropathic pain in the
Seltzer model, indicating differences in the contribution of BDNF to distinct models of neuropathy. We further used a model of
hyperalgesic priming to examine the contribution of primary afferent-derived BDNF in the transition from acute to chronic pain,
and found that primed BDNF knockout mice do not develop prolonged mechanical hypersensitivity to an inﬂammatory insult. Our
data suggest that BDNF derived from sensory neurons plays a critical role in mediating the transition from acute to chronic pain.
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Introduction
Brain-derived neurotrophic factor (BDNF), a member of the
neurotrophin family, acts as a modulator of neuronal excit-
ability and synaptic plasticity (Pezet and McMahon, 2006).
We have previously shown that nociceptor-derived BDNF
regulates the excitability of spinal neurons and plays a crucial
role in inﬂammatory pain (Zhao et al., 2006), supporting
other studies that have demonstrated neurotrophin regulation
of synaptic transmission and long term plasticity in pain
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pathways (Kerr et al., 1999; Slack et al., 2004; Melemedjian
et al., 2013). Although multiple studies support the role of
BDNF expressed throughout the nervous system in nocicep-
tive processing in the peripheral and CNS (Merighi et al.,
2008; Ferrini and De Koninck, 2013; Nijs et al., 2015), the
distinct contribution of primary afferent-derived BDNF to
chronic pain processing remains undetermined. Here we dem-
onstrate the critical role of BDNF expressed in peripheral
sensory neurons in the transition from acute to chronic pain.
BDNF expressed in dorsal root ganglia (DRG) is released
in an activity-dependent fashion in the spinal dorsal horn
to activate TrkB receptors on second order neurons or pri-
mary afferent endings (Thompson et al., 1999; Lever et al.,
2001; Chen et al., 2014b). It has long been known that
exogenous BDNF can facilitate spinal reﬂexes and increase
primary afferent evoked postsynaptic currents (Kerr et al.,
1999; Garraway et al., 2003). BDNF derived from Nav1.8-
expressing nociceptive neurons contributes to inﬂammatory
pain induced by intraplantar carrageenan and intramuscu-
lar NGF, but does not affect the development of neuro-
pathic pain in a modiﬁed Chung model (Zhao et al.,
2006). In contrast, BDNF derived from microglia drives
pain behaviour in a model of sciatic nerve cufﬁng (Coull
et al., 2005), and BDNF derived from myelinated afferents
is dramatically increased following spinal nerve transection
(Obata and Noguchi, 2006; Obata et al., 2006). However,
a pro-nociceptive role of BDNF derived from sensory
neurons alone is yet to be determined. Some studies using
models of hyperalgaesic priming have demonstrated a role
for BDNF in mediating persistent pain in migraine and
following acute inﬂammation (Melemedjian et al., 2013;
Burgos-Vega et al., 2016), which suggests that BDNF ex-
pression overall can drive chronic pain. However, whether
BDNF released from sensory neurons alone can mediate the
transition of acute to chronic pain is still unknown.
Developmental effects or compensatory mechanisms with
embryonic gene deletion can mask the normal role of genes
and expression of phenotypes in an adult system. This may be
relevant to genes, such as Bdnf, which are expressed in differ-
ent cellular populations and have temporal changes in expres-
sion throughout development (Cohen-Cory et al., 2010;
Kasemeier-Kulesa et al., 2015). We therefore used an inducible
CreERT2 system to avoid developmental problems (Feil et al.,
2009) and delete Bdnf from all sensory neurons in adult ani-
mals by crossing an Avil-CreERT2 (Advillin-CreERT2) strain
(Lau et al., 2011) with ﬂoxed Bdnf mice. We determined the
contribution of sensory neuron-derived BDNF to acute pain
processing and pain chroniﬁcation using inﬂammatory, neuro-
pathic and hyperalgesic priming models of chronic pain.
Materials and methods
Transgenic mice
Homozygous ﬂoxed Bdnf mice (Bdnfﬂ/ﬂ) carrying loxP sites
ﬂanking exon 5 in the Bdnf gene (Rios et al., 2001) were
interbred with Avil-CreERT2 mice (Lau et al., 2011) express-
ing a tamoxifen-inducible modiﬁed Cre recombinase under the
control of the peripherally-restricted sensory neuron-speciﬁc
advillin promoter to obtain Bdnfﬂ/ﬂ; Avil-CreERT2 mice.
Genotyping of mice for Bdnfﬂ/ﬂ and Avil-CreERT2 was per-
formed by standard PCR and the following primers were used
(50-30): Bdnf1 (forward) GCCTTCATGCAACCGAAGTATG
and Bdnf2 (reverse) TGTGATTGTGTTTCTGGTGAC;
Advillin1 (forward) CCCTGTTCACTGTGAGTAGG and
Advillin2 (reverse) AGTATCTGGTAGGTGCTTCCAG; and
Avil-CreERT2 (reverse) GCGATCCCTGAACATGTCCATC.
The expected sizes of amplicons are: ﬂoxed Bdnf – 487 bp;
Bdnf wild-type (WT) – 437 bp; Avil-CreERT2 – 180 bp;
Advillin wild-type – 480bp. To delete the Bdnf gene, Bdnfﬂ/ﬂ;
Avil-CreERT2 mice were treated with tamoxifen at the age of
8–12 weeks as described (Lau et al., 2011). At the same time,
the littermate Bdnfﬂ/ﬂ control mice received the same treatment
in parallel. Ten days after the tamoxifen treatment (5-day intra-
peritoneal injection, 2mg per day), Bdnfﬂ/ﬂ; Avil-CreERT2
knockout mice and Bdnfﬂ/ﬂ control mice were used for
experiments.
All animal assays performed in this study were approved by
the UK Home Ofﬁce Animals (Scientiﬁc Procedures) Act 1986.
Both female and male mice aged 8–14 weeks were kept on a
12-h light/dark cycle and maintained under standard condi-
tions (21  1C, food and water ad libitum).
Immunohistochemistry and cell
counting
Three mice from each group (Bdnfﬂ/ﬂ; Avil-CreERT2 and
Bdnfﬂ/ﬂ) were used for DRG cell counting. After CO2 euthan-
asia, L4 DRGs were excised and rapidly frozen with O.C.T.
compound on dry ice and cut in serial sections (11-mm thick).
Every eighth section was collected onto SuperfrostTM slides and
dried at room temperature for 4 h. Immumohistochemistry and
cell counting were performed as previously described (Zhao
et al., 2006). Brieﬂy, after three washes in phosphate-buffered
saline (137mm NaCl, 10mM Na2HPO4, 1.8mM KH2PO4,
2.7mM KCl, pH 7.4) containing 0.3% TritonTM X-100
(PBST), sections were incubated with 10% goat serum in
PBST at room temperature for 1 h and then incubated with
primary antibodies, mouse anti-peripherin (1:1000; Sigma,
catalogue #P5117) and rabbit anti-N200 (1:200; Sigma, cata-
logue #N4142), overnight at 4C. After three washes in PBST,
sections were incubated with secondary antibodies, goat
anti-rabbit Alexa Fluor 488 antibody (1:1000, Invitrogen,
catalogue #A-11017) and anti-mouse IgG Alexa Fluor 594
(1:1000; Invitrogen, catalogue #A-11037) for 2 h in dark.
After three washes in PBST, the sections were mounted with
VECTASHIELD HardSet Antifade Mounting Medium
(Vector, catalogue #H-1400) and visualized using a Leica
DMRB microscope, a Hamamatsu ORCA-R2 digital camera
and HCIamge 2.0.1.16 software. The sample images were ana-
lysed using the cell counter plugin for ImageJ. The number of
neurons was counted in every eighth section throughout the
DRG. Thus, the DRG was sampled every 88mm to avoid
double counting of the large diameter cells. Every visible cell
was counted whether the nucleolus was present or not. All
counting was repeated by a blinded experimenter, and the re-
sults were pooled. The percentages of NF200-positive,
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peripherin-positive and double-stained cells were calculated for
each section. Mean and standard error of mean (SEM) of these
percentages were evaluated for wild-type and mutant groups
and signiﬁcance was determined using a two-tailed unpaired
heteroscedastic t-test.
In vivo electrophysiology
Electrophysiological recordings were performed by an experi-
menter blind to genotype (Bdnfﬂ/ﬂ; Avil-CreERT2, n = 86
neurons from two male and three female mice) and their
littermate controls (Bdnfﬂ/ﬂ, n = 105 neurons from ﬁve male
and two female mice). Mice were anaesthetized with isoﬂuor-
ane (4%; 0.5 l/min N2O and 1.5 l/min O2) and secured in a
stereotaxic frame. Anaesthesia was reduced and maintained
at 1.5% isoﬂurane for the remaining duration of the experi-
ment. A laminectomy was performed to expose L3–L5 seg-
ments of the spinal cord and extracellular recordings were
made from wide-dynamic range (WDR) neurons in the deep
dorsal horn (lamina III–V, 200–600 mm) using parylene-
coated tungsten electrodes (A-M Systems) in Bdnfﬂ/ﬂ controls
and Bdnfﬂ/ﬂ; Avil-CreERT2 knockout mice. Mechanical and
thermal stimuli were applied to the peripheral receptive ﬁeld
of spinal neurons on the hindpaw glabrous skin and the
evoked activity of neurons was visualized on an oscilloscope
and discriminated on a spike amplitude and waveform basis
using a CED 1401 interface coupled to Spike2 software
(Cambridge Electronic Design). Natural stimuli (dynamic
brush, von Frey hairs 0.16–26 g, noxious prod 100 and
150 g/cm2 mechanical stimulation; thermal water jet
35–45C) were applied in ascending order of intensity to re-
ceptive ﬁelds for 10 s and the total number of evoked spikes
recorded. Statistical signiﬁcance for differences between litter-
mates and Bdnfﬂ/ﬂ; Avil-CreERT2 mice was determined using
a two-way repeated measures ANOVA with Bonferroni post-
tests for all measures.
Mouse behaviour
All behavioural experiments were performed by an experi-
menter blind to genotype [Bdnfﬂ/ﬂ n = 8 (four males and six
females), Bdnfﬂ/ﬂ; Avil-CreERT2 n = 10 (three males and ﬁve
females)]. Mechanical nociceptive thresholds were measured
using Randall-Selitto apparatus (Ugo) that applies pressure to
the tail with a 3-mm2 blunt conical probe using a 500 g cut-
off. Mechanical sensitivity of the inferior half of the abdomen
was assessed using von Frey hair application as described pre-
viously (Minett et al., 2014). Rotarod testing was performed
over 5min with the initial starting ramp increasing from 4 rpm
to 40 rpm over 30 s using a mouse-adapted apparatus (IITC).
Thermal nociceptive thresholds were determined by measuring
hindpaw withdrawal latency using the Hargreaves apparatus
(IITC) at a ramp of 1.5C/s with a 30 s cut-off and latency for
nociceptive behaviour on a hotplate (Ugo Basile) at 50C and
55C. Thermal place preference plates (Bioseb) were used to
determine temperature preference of mice to 30C (warm),
14C (cool) and 5C (cold) temperatures versus a room tem-
perature 20C plate. All place preference thermal tests were
performed with reversed plate temperature settings and the
average of the two responses used for statistical analyses.
Nociceptive behaviour to cooling acetone was measured fol-
lowing application of one acetone drop to the hindpaw and
nociceptive behaviours measured for 1min. Statistical signiﬁ-
cance for differences between littermates and BDNF knockouts
was determined using a t-test.
Formalin test
Six Bdnfﬂ/ﬂ; Avil-CreERT2 knockout mice (three males and
three females) and six Bdnfﬂ/ﬂ control mice (three males and
three females) were singly housed in Perspex boxes and
allowed to habituate to the testing environment for 30min.
Animals were then injected with formalin [intraplantar (i.pl.),
15 ml of 5% dilution of stock formalin (40% w/v) in saline] in
the hindpaw. Nociceptive behaviour was measured as licking
and biting of the injected paw only. Nociceptive behaviour
was recorded at 5min intervals for a duration of 60min and
divided into two phases, the ﬁrst phase lasting 0–10min and
the second phase 10–60min. Statistical signiﬁcance for differ-
ences between littermates and Bdnfﬂ/ﬂ; Avil-CreERT2 mice
over the time course or for comparison of biphasic behaviour
was determined using two-way repeated measures ANOVA
with Bonferroni post-tests and t-test, respectively.
Neuropathic pain models
Neuropathic pain was assessed with two peripheral nerve in-
jury models. For the partial sciatic nerve ligation model
(Seltzer model), the surgical procedure was carried out on
seven Bdnfﬂ/ﬂ control mice (one male and six females) and
eight Bdnfﬂ/ﬂ; Avil-CreERT2 knockout mice (six males and
two females) as previously described (Zhao et al., 2010).
Brieﬂy, animals were anaesthetized using isoﬂurane. A 0.5 cm
incision was made in the skin of the upper left leg and blunt
scissors were used to dissect muscle layers apart to access the
sciatic nerve. A tight ligation between one-half to one-third of
the nerve was made using 6-0 mersilk suture (Ethicon). The
skin was closed using 4-0 mersilk sutures (Ethicon). For spinal
nerve ligation, a modiﬁed version of the Kim and Chung
model (Kim and Chung, 1992; Minett et al., 2012) of periph-
eral neuropathy was adapted for use on seven Bdnfﬂ/ﬂ control
mice (three males and four females) and seven Bdnfﬂ/ﬂ; Avil-
CreERT2 knockout mice (ﬁve males and two females). Brieﬂy,
under the same anaesthesia, a midline incision was made in the
skin of the back at the L4–S2 levels and a further incision
through the left paraspinal muscle was made to access the
transverse processes at the L4–S1 levels. The L4 transverse
process was removed using a blunt ﬁne forceps and the left
L5 and L4 spinal nerves identiﬁed. The L5 spinal nerve was
separated and tightly ligated with 8-0 silk sutures and tran-
sected just distal to the ligature. The incision was closed in
layers.
Statistical signiﬁcance for differences between Bdnfﬂ/ﬂ litter-
mate controls and Bdnfﬂ/ﬂ; Avil-CreERT2 knockout mice was
determined using a two-way repeated measures ANOVA with
Bonferroni post-tests. Statistical signiﬁcance of changes in pain
behaviour over time compared to baseline within each group
was determined with a one-way repeated measures ANOVA
with Dunnett’s post-tests.
Hyperalgesic priming model
A model of hyperalgesic priming was ﬁrst established with
wild-type male C57BL/6J mice. Mechanical sensitivity of the
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hindpaw was measured using the up-down method to deter-
mine the 50% mechanical withdrawal threshold to von Frey
application (Chaplan et al., 1994). The primed group of mice
was injected with carrageenan (i.pl. 1% 20 ml, Sigma Aldrich)
on Day 0, followed by administration of prostaglandin E2
(PGE2) in the same paw (i.pl. 100 ng in 25 ml, Cayman
Chemical) in both primed and unprimed mice on Day 6
(n = 6 in both groups). We tested Bdnfﬂ/ﬂ; Avil-CreERT2
male mice (n = 6) and their littermate male controls Bdnfﬂ/ﬂ
(n = 7) in this model of hyperalgesic priming using the same
time course of drug administration. Statistical signiﬁcance for
differences between primed/unprimed mice or Bdnfﬂ/ﬂ; Avil-
CreERT2/littermates was determined using a two-way repeated
measures ANOVA with Bonferroni post-tests. Statistical
signiﬁcance of changes in pain behaviour over time compared
to baseline within each group was determined using a one-way
repeated measures ANOVA with Dunnett’s post-tests.
Statistical analysis
All values are presented as means  SEM. Data were analysed
using the GraphPad Prism 7. Student’s t-test (two-tailed) was
used for comparison of difference between two groups.
Multiple groups were compared using one-way or two-way ana-
lysis of variance with Dunnett’s or Bonferroni post-tests, respect-
ively. Differences were considered signiﬁcant at P50.05.
Results
Generation of sensory neuron-
derived BDNF knockout mice
To generate Bdnfﬂ/ﬂ; Avil-CreERT2 mice, we crossed Bdnfﬂ/ﬂ
mice with Avil-CreERT2 mice on a Bdnfﬂ/ﬂ background. The
Figure 1 Characterization of BDNF knockout mice. (A) Genotyping analysis with PCR. The representative gel analysis of PCR products
using both the BDNF primer set and the Avil-CreERT2 primer set is shown in top and bottom panels, respectively. Mice homozygous for the floxed
Bdnf band and heterozygous for the Avil-CreERT2 band were defined as Bdnffl/fl; Avil-CreERT2 mice. Mice only homozygous for the floxed Bdnf
band were defined as Bdnffl/fl littermate controls. The genomic DNA from C57BL/6J wild-type (WT) mice and heterozygous floxed Bdnf (Bdnffl/ + )
mice were used as controls. (B) DRG sections were labelled with large diameter DRG neuron marker neurofilament (in red), and small-medium
diameter DRG neuron marker peripherin (in green). Scale bar = 50 mm. (C) The total number of DRG neurons either expressing neurofilament
(NF), or peripherin (Per) in sampled L4 DRG sections, or both NF and Per were counted, respectively. (D) The proportions of neurofilament and
peripherin positive neurons in sampled L4 DRG sections are presented. Both total number and proportion are normal in BDNF knockout mice
(n = 3) compared to littermate controls (n = 3). Data were analysed with Student’s t-test and P4 0.05. Additional images—for colourblind
readers—are available in the Supplementary material.
The role of BDNF in chronic pain BRAIN 2018: 141; 1028–1039 | 1031
Downloaded from https://academic.oup.com/brain/article-abstract/141/4/1028/4831043
by UCL (University College London) user
on 11 May 2018
genotypes of offspring were analysed with standard PCR. A
homozygous ﬂoxed Bdnf band and an Avil-CreERT2 band
deﬁned BDNF conditional knockouts (Fig. 1A). In contrast,
the Bdnfﬂ/ﬂ littermate control mice only exhibited a homozy-
gous ﬂoxed Bdnf band (Fig. 1A). We have previously con-
ﬁrmed Bdnf deletion in DRG mRNA of BDNF knockout
mice using real-time qRT-PCR, showing about 70% reduc-
tion of Bdnf mRNA in DRG 10 days after tamoxifen injec-
tion (Neumann et al., 2016). The remaining 30% of Bdnf
mRNA may come from satellite glial cells (Wetmore and
Olson, 1995), or may be attributed to degraded mRNA in
DRG neurons.
Conditional BDNF deletion in adult
mice does not affect the survival of
DRG neurons
We then performed immunohistochemical staining of
lumbar DRG sections to determine whether deletion of
BDNF from sensory neurons affects survival of DRG neu-
rons using the small to medium diameter neuron
(nociceptor) marker peripherin, and large diameter neuron
marker neuroﬁlament heavy chain (NF200). Our data show
that most nociceptors were labelled with anti-peripherin,
and most large diameter DRG neurons were NF200-posi-
tive in both Bdnfﬂ/ﬂ; Avil-CreERT2 mice and Bdnfﬂ/ﬂ mice
(Fig. 1B). There was no apparent difference between tam-
oxifen-treated Bdnf conditional knockouts and littermate
controls in the total number and proportion of neuroﬁla-
ment and peripherin-positive neurons (Fig. 1C and D). This
is similar to our previous ﬁndings with BDNF deletion from
Nav1.8-expressing neurons (Zhao et al., 2006).
Acute pain processing
To assess sensory coding of spinal neurons, we used extra-
cellular recordings of evoked activity of L4 deep dorsal
horn WDR neurons in Bdnfﬂ/ﬂ mice and Bdnfﬂ/ﬂ; Avil-
CreERT2 mice. Mechanical and thermal stimuli were
applied to the peripheral hindpaw receptive ﬁeld of neurons
and evoked action potentials were recorded as previously
described (Sikandar et al., 2013; Minett et al., 2015). For
mechanical sensory coding, we compared evoked activity of
Figure 2 Evoked activity of wide-dynamic range neurons in deep dorsal horn was assessed by in vivo electrophysiology.
(A) Evoked activity to mechanical punctate stimulated with von Frey hair on hindpaw. (B) Thermal stimuli. (C) Noxious cold. (D) Dynamic brush
and prod stimulation. Eighty-six WDR neurons from Bdnffl/fl; Avil-CreERT2 and 105 WDR neurons from Bdnffl/fl mice were recorded. Data were
analysed with two-way repeated measures ANOVA with Bonferroni post-tests and P4 0.05 in all measures.
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Figure 3 Motor function and acute pain behaviour tests. (A) Motor function was assessed with rotarod activity with measures of speed
(left), time spent on rotarod (middle) and distance travelled (right). (B) Mechanical pain thresholds were examined with Randall-Sellitto apparatus
for the hindpaw (left) and tail (right). (C) Mechanical sensitivity of the abdominal wall was measured with application of von Frey (vF) hairs.
(D) Thermal place preference was measured at 30, 14 and 4C. (E) Hindpaw thermal pain thresholds to ramped heat were assessed with the
Hargreaves test. (F) Hindpaw sensitivity to cooling was measured with acetone. (G) Latencies for nocifensive behaviour elicited by noxious heat
were examined with a hotplate test. Data were analysed with Student’s t-test (*P5 0.05, **P5 0.01).
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dorsal horn neurons to a range of intensities of punctate
von Frey hairs (Fig. 2A), as well as two noxious prods and
a low threshold brush stimulation applied to the whole
receptive ﬁeld of the hindpaw (Fig. 2D). For thermal sen-
sory coding, we compared evoked activity to innocuous
and noxious heat (Fig. 2B), as well as noxious cold with
ethyl chloride (Fig. 2C). Dorsal horn neurons in both con-
ditional BDNF knockouts and littermate controls showed
graded coding to increasing intensities of both mechanical
and thermal stimuli. However, we observed no signiﬁcant
difference between groups of evoked activity to any mech-
anical or thermal stimulation parameter (P4 0.05 in all
measures, two-way repeated measures ANOVA with
Bonferroni post-tests). These ﬁndings indicate that deletion
of Bdnf from DRG does not alter normal spinal sensory
coding of mechanical and thermal stimuli.
Standardized behavioural assays were used to assess ther-
mal and mechanical pain thresholds in BDNF knockout
mice (Fig. 3). Deletion of Bdnf from sensory neurons had
no impact on motor function, as shown by normal rotarod
activities measured in speed (Fig. 3A, t-test, P = 0.21), time
spent on the rotarod (Fig. 3A, t-test, P = 0.26) and distance
travelled (Fig. 3A, t-test, P = 0.18). We also observed no
signiﬁcant difference in mechanical pain thresholds using
the Randall-Sellitto test with a noxious probe applied to
the paw (Fig. 3B, t-test, P = 0.72) and tail (Fig. 3B, t-test,
P = 0.21) (Randall and Selitto, 1957). There was also no
signiﬁcant difference between these two groups on the 50%
mechanical withdrawal thresholds for ﬁne ﬁlament von
Frey hairs applied to the abdomen (Fig. 3C, t-test,
P = 0.99).
Thermal place preference for innocuous warm (30C),
cool (14C) and noxious cold (5C) revealed no changes
in thermal sensory function in the BDNF knockouts
(Fig. 3D, t-test, P = 0.61, P = 0.91 and P = 0.36, respect-
ively), and thermal pain thresholds in the Hargreaves test
was comparable to littermate controls (Fig. 3E, t-test,
P = 0.30) (Hargreaves et al., 1988). Acetone applied to
the hindpaw did not evoke signiﬁcantly different pain be-
haviours from wild-type mice, also indicating no altered
sensitivity to cold stimulation (Fig. 3F, t-test, P = 0.47).
However, we did observe a hyposensitivity to noxious
heat at temperatures of 50C and 55C in the hotplate
test, which assesses supraspinally mediated nociceptive be-
haviours (Fig. 3G, t-test, P = 002 and P = 0.03, respectively)
(Woolfe and Macdonald, 1944). This mild thermal pheno-
type is similar to what we have previously reported with
BDNF deletion from Nav1.8-expressing DRG neurons
(Zhao et al., 2006).
Chronic pain models of inflammation,
neuropathy and hyperalgesic priming
We used the intraplantar formalin test to assess effects of
BDNF deletion from sensory neurons on inﬂammatory pain
behaviour (Hunskaar et al., 1985) (Fig. 4). Bdnfﬂ/ﬂ; Avil-
CreERT2 mice show comparable nocifensive behaviour to
littermate Bdnfﬂ/ﬂ control mice in the ﬁrst phase but show
deﬁcits in the second phase (P50.001, t-test). To deter-
mine the effects on evoked pain behaviour following neur-
opathy, we used the modiﬁed Chung model and partial
sciatic nerve ligation model (Seltzer model). Following the
modiﬁed Chung model of neuropathy (Fig. 5A), we
observed prolonged mechanical hypersensitivity for the dur-
ation of 28 days in Bdnfﬂ/ﬂ control mice (P5 0.05 on Days
14, 21 and 28, and P5 0.01 on Days 3, 5, 7 and 10, one-
way repeated measures ANOVA with Dunnett’s post-tests).
In Bdnfﬂ/ﬂ; Avil-CreERT2 mice, we observed an acute drop
in mechanical withdrawal thresholds lasting up to 14 days
(P5 0.05 on Days 5 and 14, P5 0.01 on Days 3, 7 and
10, one-way repeated measures ANOVA with Dunnett’s
post-tests), but began to see recovery from Day 5 followed
by full recovery of withdrawal thresholds back to baseline
in the chronic, later phases of the model at Days 21 and 28
(P4 0.05 on Days 21 and 28, one-way repeated measures
ANOVA with Dunnett’s post-tests). Following partial
Figure 4 Formalin test. (A) Time course of formalin-induced nociceptive responses. (B) Phase I and phase II summed nocicefensive be-
haviour. A significant attenuation of pain behaviour in phase II was observed in BDNF knockout mice. Bdnffl/fl (n = 6) and Bdnffl/fl; Avil-CreERT2
(n = 6) were used. Data were analysed with either two-way repeated measures ANOVA with Bonferroni post-tests (A, **P5 0.01, ***P5 0.001)
or Student’s t-test (B, ***P5 0.001).
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sciatic nerve ligation (Fig. 5B), we observed persistent
mechanical hypersensitivity in both Bdnfﬂ/ﬂ control mice
and Bdnfﬂ/ﬂ; Avil-CreERT2 knockout mice (P5 0.05 and
P50.01 in both groups at all measured time points, one-
way repeated measures ANOVA with Dunnett’s post-tests).
Our combined data from the inﬂammatory formalin test
and modiﬁed Chung model suggest that BDNF expressed
in sensory neurons drives chronic, but not acute, nocicep-
tive processes in inﬂammatory and some transection-related
neuropathic pain.
To explore the distinct contribution of primary afferent-
derived BDNF in acute and chronic nociceptive processing
further, we established a model of hyperalgesic priming to
model the transition from acute to chronic pain in rodents,
as described in other studies (Aley et al., 2000; King et al.,
2012) (Fig. 6). Here, a prior injury can prime pain path-
ways to produce chronic pain following a subsequent
insult. First, we validated this model of hyperalgesic prim-
ing in C57BL/6 J wild-type mice using an intraplantar prim-
ing injection of 25 ml 1% carrageenan. This induces a
transient mechanical hypersensitivity with a recovery
to baseline thresholds within 72 h (Fig. 6A). At Day 6,
intraplantar injection of PGE2 leads to a short-lasting
mechanical hypersensitivity in unprimed control mice,
with recovery to baseline thresholds within 1 h (Fig. 6A:
one-way repeated measures ANOVA with Dunnett’s post-
tests, P5 0.001 at 30min post-PGE2 in unprimed group).
In contrast, primed mice develop long-lasting mechanical
hypersensitivity lasting up to 7 days (Fig. 6A: one-way re-
peated measures ANOVA with Dunnett’s post-tests,
P5 0.001 at all time points post-PGE2 in primed group).
We used this model to determine the contribution of BDNF
to the transition from acute to chronic pain (Fig. 6B). We
found that priming with intraplantar injection of carra-
geenan induced a transient mechanical hypersensitivity in
both Bdnf conditional knockouts and littermate controls.
Intraplantar injection of carrageenan alone is an established
model of acute inﬂammation, and like our ﬁndings in the
ﬁrst phase formalin behaviour (Fig. 4), we observed no
difference in nociceptive behaviour between BDNF knock-
outs and littermate controls. Littermate control mice
recovered to baseline thresholds within 72 h (Fig. 6B, one-
way repeated measures ANOVA with Dunnett’s post-tests,
P5 0.001 up to 48 h post-carrageenan in Bdnfﬂ/ﬂ group).
However, we observed a signiﬁcantly faster recovery
to baseline thresholds in Bdnfﬂ/ﬂ; Avil-CreERT2 mice
(Fig. 6B, one-way repeated measures ANOVA with
Dunnett’s post-tests, P5 0.001 up to 1 h post-carrageenan
in Bdnfﬂ/ﬂ; Avil-CreERT2 group). At Day 6, mechanical
withdrawal thresholds had returned to baseline values
and effects of intraplantar injection of PGE2 were assessed.
As demonstrated in our validation study in wild-type
C57BL/6J mice (Fig. 6A), primed Bdnfﬂ/ﬂ littermate con-
trols developed prolonged mechanical hypersensitivity last-
ing up to 7 days post-PGE2 (Fig. 6B, one-way repeated
measures ANOVA with Dunnett’s post-tests, P5 0.001
up to Day 7 post-PGE2 in Bdnfﬂ/ﬂ group). In contrast,
primed Bdnfﬂ/ﬂ; Avil-CreERT2 mice developed a shorter
lasting hypersensitivity lasting only up to 60min post-
PGE2 (Fig. 6B, one-way repeated measures ANOVA with
Dunnett’s post-test, P5 0.001 up to 1 h post-PGE2 in
Bdnfﬂ/ﬂ; Avil-CreERT2 group).
Discussion
We deleted the Bdnf gene from adult peripheral sensory
neurons to determine its contribution to acute and chronic
pain processing. Our combined behavioural, electrophysio-
logical and immunohistochemistry data show that BDNF
released from sensory neurons does not signiﬁcantly con-
tribute to acute pain, but is necessary for the transition
from acute to chronic inﬂammatory pain and some neuro-
pathic pain states.
Tissue-speciﬁc gene ablation can provide important infor-
mation about the relevance of new drug targets, and time-
speciﬁc gene deletion overcomes potential physiological
compensatory mechanisms that can mask the true pheno-
typic contribution of a gene (Feil et al., 1997; Metzger and
Chambon, 2001). Advillin (encoded by Avil) is a pan-
Figure 5 Neuropathic pain models. (A) A modified Chung
surgical model was used to assess development of neuropathic pain.
(B) The Seltzer surgical model of neuropathy. Bdnffl/fl (n = 7) and
Bdnffl/fl; Avil-CreERT2 mice (n = 7) were tested in these two models.
Data were analysed using two-way repeated measures ANOVA with
Bonferroni post-tests (*P5 0.05), one-way repeated measures
ANOVA with Dunnett’s post-tests for Bdnffl/fl group (^P5 0.05,
^^P5 0.01), and one-way repeated measures ANOVA with
Dunnett’s post-tests for Bdnffl/fl; Avil-CreERT2 group (xP5 0.05,
xxP5 0.01).
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neuronal marker of spinal and cranial sensory ganglia
(Marks et al., 1998; Ravenall et al., 2002; Zurborg et al.,
2011), and we have previously generated BAC transgenic
mice using the Avil promoter to drive a tamoxifen-indu-
cible CreERT2 recombinase construct that permits gene de-
letion in adult animals (Lau et al., 2011). Here we used
ﬂoxed Bdnf mice for Cre-mediated excision of Bdnf from
sensory ganglia to determine the contribution of primary
afferent-derived BDNF on the transition from acute to
chronic pain. To assess the effects of Bdnf deletion from
sensory neurons at the cell population level in DRG, we
used immunostaining with the neuronal markers
neuroﬁlament NF200 and peripherin. We found no differ-
ence in the total number of lumbar DRG neurons or pro-
portions of large or small/medium diameter afferents
following Bdnf deletion. This is in line with our previous
ﬁndings that Bdnf deletion from Nav1.8-expressing neu-
rons, an estimated 75% of all DRG neurons in lumbar
ganglia (Shields et al., 2012), also results in a normal com-
plement of DRG neurons (Zhao et al., 2006).
To determine potential changes in spinal excitability we
performed in vivo electrophysiological recordings from
WDR neurons in the deep dorsal horn. WDR neurons in
the deep dorsal horn receive converging primary afferent
input, and their neural coding to peripheral stimulation
conveys whether peripheral and central nociceptive process-
ing has been signiﬁcantly altered (Abrahamsen et al., 2008;
Bannister et al., 2011; Sikandar et al., 2013; O’Neill et al.,
2015). We measured evoked activity of spinal neurons to
mechanical and thermal stimuli of low- and high-threshold
intensities and found no signiﬁcant impairment of graded
coding to sensory stimulation in BDNF knockout mice
(Fig. 2). We also found no difference in the overall
amount of neuronal ﬁring evoked by peripheral stimula-
tion. These ﬁndings are in line with the normal neuronal
complement of DRG neurons, indicating that peripheral
input to the spinal cord is normal following Bdnf deletion
from sensory neurons. Moreover, behavioural assays mea-
suring acute reﬂexes to noxious stimuli showed no signiﬁ-
cant difference between BDNF knockout mice and
littermate controls to mechanical, cold and most thermal
assays (Fig. 3). However, the knockout mice were hyposen-
sitive to the hotplate assay—this recruits bulbospinal
reﬂexes, indicating that BDNF expression in sensory gang-
lia contributes to reﬂexes mediated from the brainstem. We
have previously observed a similar hotplate phenotype fol-
lowing BDNF deletion from Nav1.8-expressing neurons
(Zhao et al., 2006).
Several lines of evidence support the role of enhanced
DRG and spinal BDNF expression in persistent pain that
follows injury-induced sensitization of nociceptors (Cho
et al., 1997, 1998; Lever et al., 2003; Coull et al., 2005;
Li et al., 2006; Lin et al., 2011; Melemedjian et al., 2013).
However, the relative importance of BDNF released either
from microglia or sensory neurons in chronic pain states is
still unclear (Coull et al., 2005; Zhuo et al., 2011), and the
contribution of microglial activity to persistent pain is fur-
ther confounded by well-established sex differences in
immune-related nociceptive processing (Sorge et al., 2011,
2015). In this study, we examine the role of primary affer-
ent-derived BDNF on pain processing using both male and
female mice.
To study the contribution of sensory BDNF to the devel-
opment and maintenance of chronic pain, we used the for-
malin model of inﬂammation, a modiﬁed Chung and
Seltzer models of neuropathy and a model of hyperalgesic
priming. The formalin model entails biphasic pain behav-
iour—the ﬁrst phase reﬂects acute, peripheral hypersensitiv-
ity and the second phase relates to chronic maintenance of
Figure 6 Hyperalgesic priming model. (A) A model of
hyperalgesic priming with wild-type C57BL/6J mice shows that
priming mice with intraplantar carrageenan (first dotted line) con-
fers prolonged mechanical hypersensitivity to PGE2 (second dotted
line) compared to control unprimed mice (n = 6 in both groups).
(B) Bdnffl/fl; Avil-CreERT2 mice (n = 6) and their littermate controls
Bdnffl/fl control mice (n = 7) develop transient mechanical hyper-
sensitivity following the priming injection of intraplantar carragee-
nan, but BDNF mutant mice do not develop prolonged mechanical
hypersensitivity following intraplantar PGE2, unlike their littermate
controls. Data were analysed with two-way repeated measures
ANOVA with Bonferroni post-tests (*P5 0.05, **P5 0.01,
***P5 0.001), one-way repeated measures ANOVA with Dunnett’s
post-tests for primed/BDNFfl/fl groups (^^^P5 0.001), and one-way
repeated measures ANOVA with Dunnett’s post-tests for
unprimed/Bdnffl/fl; Avil-CreERT2 groups (xxxP5 0.001).
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pain through central sensitization (Tjolsen et al., 1992;
Berge, 2011). We found comparable ﬁrst phase nocifensive
behaviour between BDNF knockouts and littermate con-
trols, but signiﬁcantly reduced second phase nocifensive be-
haviour in knockouts (Fig. 4). Similarly, we found that
nerve-injury induced mechanical hypersensitivity was com-
parable to littermates in the acute phase following a mod-
iﬁed Chung surgery, but BDNF knockout mice showed
recovery of pain behaviour in a later chronic phase from
3 weeks after surgery (Fig. 5). Our data in the formalin and
modiﬁed Chung surgery models suggest that BDNF signal-
ling in sensory neurons is important for chronic, but not
acute, pain processing.
Notably, we did not observe any difference in the devel-
opment of mechanical hypersensitivity in the Seltzer model
between BDNF knockout mice and littermate controls at
any time point (Fig. 5B). Our observations support previ-
ous ﬁndings that the development of chronic pain in the
modiﬁed Chung model is dependent on the expression of
BDNF in sensory neurons, unlike partial sciatic nerve liga-
tion (Obata et al., 2006). Previous studies have also re-
ported differences in behavioural phenotypes (Kim et al.,
1997; Dowdall et al., 2005) and in the contribution of
distinct neuronal subsets across different rodent models of
neuropathy (Minett et al., 2012). Moreover, differences in
levels of BDNF expression in DRG following distinct rhi-
zotomy and transection models of neuropathy have been
reported previously (Obata and Noguchi, 2006; Obata
et al., 2006).
We also validated a model of hyperalgesic priming to
determine the role of sensory BNDF in the transition
from acute to chronic pain. Hyperalgesic priming of the
nociceptive system reﬂects long-lasting, latent hyper-respon-
siveness of nociceptors to inﬂammatory mediators subse-
quent to an inﬂammatory or neuropathic insult (Reichling
and Levine, 2009). In rodents, repeated injections of algo-
genic substances with short-lasting acute effects can pro-
duce long-lasting hypersensitivity (Aley et al., 2000;
Parada et al., 2003; Sluka et al., 2003; Melemedjian
et al., 2014). Here we used intraplantar carrageenan as a
priming agent (Fig. 6) to produce prolonged mechanical
hypersensitivity to intraplantar PGE2 compared to animals
that had not been primed. In Bdnfﬂ/ﬂ mice, we conﬁrmed
that priming with carrageenan precipitates long-lasting
changes in PGE2-induction of pain behaviour. In contrast,
we found that administration of intraplantar carrageenan
in BDNF knockout mice produces an acute mechanical
hypersensitivity, but does not prime mice to develop pro-
longed hypersensitivity to PGE2. Our data suggest that
BDNF expression in sensory neurons mediates the transi-
tion from acute to chronic pain in a model of hyperalgesic
priming. Some forms of hyperalgesic priming have been
shown to be sexually dimorphic (Joseph et al., 2003;
Khomula et al., 2017). Accordingly, we only used male
mice for our hyperalgesic priming experiments; however,
our other chronic pain models were carried out with
mixed genders, and our ﬁndings overall suggest that
primary afferent-derived BDNF contributes to pain chron-
iﬁcation in both males and females—despite the speciﬁcity
of this particular hyperalgesic priming model to precipitate
a behavioural phenotype in males only. Other studies sup-
port our ﬁndings of this pro-nociceptive role of BDNF in
pain chroniﬁcation, where spinal BDNF mediates pro-
longed PGE2 sensitivity in rodents primed with IL-6
(Melemedjian et al., 2013) and sequestering BDNF in
the cisterna magna can prevent IL-6-mediated hyperalge-
sic priming in a model of migraine (Burgos-Vega et al.,
2016).
An important implication of our ﬁndings is that BDNF
expressed in sensory neurons is not essential for acute
mechanical pain, but is critical for the transition from
acute to chronic pain in models of inﬂammation, neur-
opathy and hyperalgesic priming. Studies of long term po-
tentiation suggest that both pre- and postsynaptic release of
BDNF regulates consolidation of late long term potenti-
ation (Dean et al., 2009; Jourdi et al., 2009). Groth and
colleagues have shown that BDNF-like immunoreactivity
increased by 50% in laminae I/II from tissue obtained 8 h
after intraplantar injections of carrageenan and this in-
crease was blocked by intrathecal injection of BDNF anti-
sense oligos (Groth and Aanonsen, 2002). Previous studies
have also shown that spinal BDNF regulates synthesis of
atypical PKCs via mTORC1 and enhances PKM phos-
phorylation (Melemedjian et al., 2013, 2014). These intra-
cellular signalling events are required for the initiation and
maintenance of chronic pain. Alongside postsynaptic effects
of BDNF-TrkB signalling, BDNF also reduces presynaptic
inhibition following nerve injury through a depolarizing
shift in the reversal potential and reduction in conductance
of GABAA receptors in primary afferents (Chen et al.,
2014a). These may be important mechanisms underlying
the transition to and maintenance of chronic pain at the
spinal level. Different sources of BDNF may also drive
nociceptive mechanisms in different preclinical pain
models, i.e. the gender-speciﬁc contribution of microglial
BDNF to chronic pain in a model of sciatic nerve cufﬁng
(Coull et al., 2005). A mechanistic discrepancy of
neurotrophin signalling between rodent models likely
underlies our ﬁndings that BDNF released from sensory
neurons is essential for the development of chronic pain
in a model of full, but not partial, nerve ligation
(Obata et al., 2006).
In conclusion, our ﬁndings demonstrate the pro-nocicep-
tive role of primary-afferent derived BDNF in mediating the
transition from acute to chronic pain. These ﬁndings sup-
port the therapeutic potential of modulating BDNF for
chronic pain syndromes (Nijs et al., 2015). Because
BDNF expression is ubiquitously expressed in the nervous
system, the development of targeted gene therapies for sub-
sets of sensory neurons holds promise for providing ad-
equate pain relief and overcoming side-effects arising
from central modulation (Glorioso and Fink, 2009; Fink
et al., 2011).
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